Standardized Insect Venom Allergenic Extract [EPC]

Standardized Insect Venom Allergenic Extract [EPC] was reported 7244 times

Drugs of the Standardized Insect Venom Allergenic Extract [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 TESTICULAR HAEMORRHAGE 6 0.0682
1 FAECAL VOLUME DECREASED 7 0.0146
2 GROIN INFECTION 7 0.0127
3 MYCOPLASMA INFECTION 8 0.0102
4 SMALL FIBRE NEUROPATHY 7 0.0095
5 EXPOSURE TO TOXIC AGENT 29 0.0091
6 PENILE HAEMORRHAGE 7 0.0086
7 THERAPEUTIC REACTION TIME DECREASED 23 0.0079
8 SERUM FERRITIN DECREASED 8 0.0046
9 INFUSION SITE MASS 5 0.0046
10 MAGNETIC RESONANCE IMAGING ABNORMAL 5 0.0042
11 WEIGHT BEARING DIFFICULTY 10 0.0037
12 CHRONIC FATIGUE SYNDROME 5 0.0036
13 INFUSION SITE HAEMORRHAGE 11 0.0033
14 DEFAECATION URGENCY 23 0.0033
15 INJECTION SITE PAPULE 15 0.0033
16 INJECTION RELATED REACTION 5 0.0030
17 JOINT CREPITATION 6 0.0030
18 ARTHROPOD STING 5 0.0030
19 DEVICE INFUSION ISSUE 7 0.0028
20 ABNORMAL FAECES 23 0.0028
21 AORTIC VALVE STENOSIS 5 0.0028
22 DRUG MONITORING PROCEDURE NOT PERFORMED 5 0.0028
23 HYPERTONIC BLADDER 8 0.0028
24 VOMITING PROJECTILE 8 0.0028
25 MIDDLE EAR EFFUSION 6 0.0027
26 DERMATITIS CONTACT 31 0.0027
27 BODY TEMPERATURE ABNORMAL 5 0.0027
28 BLOOD IRON INCREASED 5 0.0027
29 ABDOMINAL MASS 7 0.0026
30 ADRENAL DISORDER 5 0.0026
31 GINGIVAL RECESSION 5 0.0026
32 TENDON PAIN 19 0.0025
33 CARTILAGE INJURY 6 0.0024
34 VITAMIN B12 DECREASED 7 0.0024
35 HYPERACUSIS 9 0.0024
36 INFREQUENT BOWEL MOVEMENTS 6 0.0024
37 BODY TEMPERATURE FLUCTUATION 5 0.0024
38 LIVEDO RETICULARIS 5 0.0024
39 INTESTINAL STENOSIS 10 0.0024
40 UMBILICAL HERNIA 11 0.0024
41 INFUSION SITE BRUISING 5 0.0023
42 REACTION TO DRUG EXCIPIENTS 5 0.0023
43 EYELID DISORDER 5 0.0022
44 QUALITY OF LIFE DECREASED 29 0.0022
45 THERAPY CHANGE 21 0.0021
46 MUSCLE FATIGUE 9 0.0021
47 WALKING AID USER 14 0.0021
48 NECK MASS 6 0.0021
49 PAROSMIA 16 0.0021
50 PARANASAL SINUS DISCOMFORT 8 0.0021
51 BLOOD IRON DECREASED 25 0.0021
52 GASTROINTESTINAL OBSTRUCTION 5 0.0021
53 INFUSION SITE SWELLING 13 0.0021
54 FAECES SOFT 15 0.0021
55 HAEMORRHAGIC ANAEMIA 9 0.0020
56 BRAIN FOG 32 0.0020
57 TACHYPHRENIA 7 0.0020
58 FACIAL PAIN 18 0.0020
59 HYPERKERATOSIS 11 0.0020
60 TENDON DISORDER 13 0.0020
61 ABDOMINAL HERNIA 9 0.0020
62 IMPAIRED WORK ABILITY 42 0.0020
63 SKIN WEEPING 7 0.0020
64 FREQUENT BOWEL MOVEMENTS 53 0.0020
65 TRIGGER FINGER 8 0.0020
66 TENDONITIS 30 0.0019
67 YELLOW SKIN 9 0.0019
68 MULTIPLE ALLERGIES 15 0.0019
69 SEASONAL ALLERGY 27 0.0019
70 ABDOMINAL ADHESIONS 6 0.0019
71 NASAL DISCOMFORT 15 0.0019
72 POLYMYALGIA RHEUMATICA 6 0.0019
73 FEELING OF BODY TEMPERATURE CHANGE 11 0.0019
74 ANTINUCLEAR ANTIBODY POSITIVE 6 0.0018
75 POSTURE ABNORMAL 6 0.0018
76 CHAPPED LIPS 8 0.0018
77 PRODUCT SUBSTITUTION ISSUE 106 0.0018
78 MIGRAINE WITH AURA 5 0.0018
79 CLUMSINESS 5 0.0018
80 HYPERAESTHESIA 15 0.0018
81 ELECTRIC SHOCK SENSATION 5 0.0018
82 INFUSION SITE PAIN 23 0.0018
83 OESOPHAGEAL PAIN 7 0.0018
84 VITAMIN D DECREASED 15 0.0018
85 EAR DISORDER 8 0.0017
86 REGURGITATION 6 0.0017
87 PHOTOPSIA 11 0.0017
88 EYELID MARGIN CRUSTING 5 0.0017
89 MUSCLE TIGHTNESS 28 0.0017
90 FINE MOTOR SKILL DYSFUNCTION 5 0.0017
91 FOREIGN BODY SENSATION IN EYES 11 0.0017
92 FEELING OF DESPAIR 8 0.0017
93 SPINAL COLUMN STENOSIS 8 0.0017
94 PRODUCT FORMULATION ISSUE 11 0.0017
95 NORMOCHROMIC NORMOCYTIC ANAEMIA 5 0.0017
96 DYSSTASIA 48 0.0016
97 POOR VENOUS ACCESS 17 0.0016
98 BLOOD PHOSPHORUS DECREASED 6 0.0016
99 SCIATICA 26 0.0016
100 RECTAL CANCER 5 0.0016
101 HORDEOLUM 7 0.0016
102 PRE-EXISTING CONDITION IMPROVED 10 0.0016
103 TONGUE DISCOLOURATION 7 0.0016
104 SPINAL OSTEOARTHRITIS 14 0.0016
105 BODY HEIGHT DECREASED 17 0.0016
106 GASTROENTERITIS VIRAL 28 0.0015
107 SKIN WARM 9 0.0015
108 SENSATION OF HEAVINESS 6 0.0015
109 INFUSION SITE ERYTHEMA 13 0.0015
110 INTERVERTEBRAL DISC DEGENERATION 14 0.0015
111 ANORECTAL DISCOMFORT 8 0.0015
112 INSURANCE ISSUE 23 0.0015
113 BLEPHARITIS 6 0.0015
114 FOOD POISONING 8 0.0015
115 LOCAL SWELLING 26 0.0015
116 LOWER GASTROINTESTINAL HAEMORRHAGE 11 0.0015
117 BURNING SENSATION 104 0.0015
118 MUSCLE DISORDER 12 0.0015
119 FEELING DRUNK 11 0.0015
120 DRY THROAT 15 0.0015
121 IMPAIRED QUALITY OF LIFE 21 0.0015
122 GASTROINTESTINAL PAIN 16 0.0015
123 DIZZINESS POSTURAL 14 0.0014
124 THERAPY CESSATION 74 0.0014
125 DISSOCIATION 11 0.0014
126 SCRATCH 15 0.0014
127 TONGUE DISCOMFORT 6 0.0014
128 INCORRECT DRUG ADMINISTRATION RATE 6 0.0014
129 SINUS CONGESTION 19 0.0014
130 VEIN DISORDER 7 0.0014
131 NECK PAIN 78 0.0014
132 BLOOD MAGNESIUM DECREASED 12 0.0014
133 GINGIVAL PAIN 11 0.0014
134 VULVOVAGINAL PRURITUS 7 0.0014
135 REFUSAL OF TREATMENT BY PATIENT 9 0.0014
136 PANIC ATTACK 50 0.0014
137 COORDINATION ABNORMAL 19 0.0014
138 TOOTH FRACTURE 15 0.0014
139 NEURALGIA 33 0.0014
140 DECREASED INTEREST 8 0.0014
141 HAIR DISORDER 11 0.0013
142 VITAMIN D DEFICIENCY 13 0.0013
143 BALANCE DISORDER 115 0.0013
144 BONE DISORDER 24 0.0013
145 FIBROMYALGIA 32 0.0013
146 VULVOVAGINAL BURNING SENSATION 8 0.0013
147 NERVE COMPRESSION 12 0.0013
148 STRESS FRACTURE 7 0.0013
149 BEDRIDDEN 17 0.0013
150 LACRIMATION INCREASED 39 0.0013
151 MASS 18 0.0013
152 MUSCLE RUPTURE 5 0.0013
153 DRUG EFFECT LESS THAN EXPECTED 19 0.0013
154 TOOTH ABSCESS 13 0.0013
155 SWELLING OF EYELID 8 0.0013
156 NAIL DISCOLOURATION 5 0.0013
157 SPINAL DISORDER 12 0.0013
158 RENAL CYST 10 0.0013
159 HYPERPHAGIA 5 0.0013
160 GROIN PAIN 11 0.0013
161 OBSTRUCTION 5 0.0013
162 PRODUCT COMMUNICATION ISSUE 11 0.0012
163 PROCTALGIA 8 0.0012
164 NEUROPATHY PERIPHERAL 118 0.0012
165 ENURESIS 5 0.0012
166 FRUSTRATION TOLERANCE DECREASED 10 0.0012
167 HIATUS HERNIA 16 0.0012
168 IMPAIRED DRIVING ABILITY 14 0.0012
169 MIDDLE INSOMNIA 23 0.0012
170 ORAL DISORDER 9 0.0012
171 PHARYNGEAL SWELLING 12 0.0012
172 RETCHING 26 0.0012
173 TINNITUS 56 0.0012
174 EXERCISE TOLERANCE DECREASED 7 0.0012
175 TENDON RUPTURE 15 0.0012
176 MOUTH SWELLING 7 0.0012
177 CYST 15 0.0012
178 POST-TRAUMATIC STRESS DISORDER 8 0.0012
179 ONYCHOMADESIS 5 0.0012
180 EYE PAIN 67 0.0012
181 ATTENTION DEFICIT HYPERACTIVITY DISORDER 5 0.0012
182 MIGRAINE 113 0.0012
183 MUSCULOSKELETAL PAIN 62 0.0012
184 EAR PAIN 23 0.0012
185 SINUS HEADACHE 7 0.0012
186 THIRST 21 0.0012
187 BOWEL MOVEMENT IRREGULARITY 9 0.0012
188 ODYNOPHAGIA 7 0.0012
189 MUSCLE SPASMS 215 0.0012
190 EUPHORIC MOOD 12 0.0012
191 MUSCLE TWITCHING 27 0.0012
192 INITIAL INSOMNIA 12 0.0012
193 EAR DISCOMFORT 12 0.0012
194 MUSCULOSKELETAL CHEST PAIN 18 0.0012
195 ONYCHOCLASIS 8 0.0012
196 VARICOSE VEIN 6 0.0012
197 PARANOIA 20 0.0012
198 TOOTHACHE 21 0.0012
199 LYMPHOEDEMA 8 0.0012
200 COGNITIVE DISORDER 54 0.0012
201 PELVIC FRACTURE 9 0.0012
202 RESTLESS LEGS SYNDROME 21 0.0012
203 NOCTURIA 14 0.0012
204 PAIN OF SKIN 31 0.0012
205 FLUSHING 117 0.0011
206 POLLAKIURIA 48 0.0011
207 IMMOBILE 5 0.0011
208 DIVERTICULUM INTESTINAL 5 0.0011
209 SCAB 13 0.0011
210 GAIT DISTURBANCE 217 0.0011
211 GINGIVAL SWELLING 5 0.0011
212 HEAD DISCOMFORT 20 0.0011
213 HYPOAESTHESIA ORAL 17 0.0011
214 PARAESTHESIA 177 0.0011
215 INFUSION SITE EXTRAVASATION 7 0.0011
216 HAIR TEXTURE ABNORMAL 15 0.0011
217 MOVEMENT DISORDER 36 0.0011
218 MADAROSIS 13 0.0011
219 VITREOUS FLOATERS 11 0.0011
220 PARALYSIS 16 0.0011
221 BODY TEMPERATURE DECREASED 11 0.0011
222 GASTROINTESTINAL INFECTION 10 0.0011
223 ANAL ABSCESS 6 0.0011
224 BLOOD PRESSURE INCREASED 170 0.0011
225 IRON DEFICIENCY 5 0.0011
226 ANAL INCONTINENCE 10 0.0011
227 ACTIVITIES OF DAILY LIVING IMPAIRED 22 0.0011
228 SCAR 19 0.0011
229 BLADDER DISORDER 11 0.0011
230 SKIN LACERATION 12 0.0011
231 ANGER 37 0.0011
232 GASTROOESOPHAGEAL REFLUX DISEASE 88 0.0011
233 MACULAR DEGENERATION 13 0.0011
234 INCREASED TENDENCY TO BRUISE 10 0.0011
235 BLINDNESS TRANSIENT 8 0.0011
236 CYSTIC FIBROSIS 6 0.0011
237 AGEUSIA 27 0.0011
238 MYALGIA 184 0.0011
239 ARTHROPOD BITE 8 0.0011
240 AMNESIA 70 0.0011
241 HEART RATE ABNORMAL 6 0.0011
242 FLATULENCE 61 0.0011
243 ROSACEA 5 0.0011
244 TREMOR 178 0.0011
245 CARPAL TUNNEL SYNDROME 15 0.0011
246 TEMPERATURE INTOLERANCE 11 0.0011
247 PHOTOPHOBIA 20 0.0011
248 DYSGRAPHIA 7 0.0011
249 FAECES DISCOLOURED 23 0.0011
250 CHRONIC LYMPHOCYTIC LEUKAEMIA 5 0.0011
251 MICTURITION URGENCY 12 0.0010
252 NEUROLOGICAL SYMPTOM 6 0.0010
253 ENDOMETRIOSIS 5 0.0010
254 INFLUENZA LIKE ILLNESS 86 0.0010
255 DYSPHONIA 61 0.0010
256 SKIN ATROPHY 6 0.0010
257 INCONTINENCE 11 0.0010
258 APHAGIA 5 0.0010
259 RHINORRHOEA 67 0.0010
260 TASTE DISORDER 21 0.0010
261 VERTIGO 63 0.0010
262 CONCUSSION 8 0.0010
263 PRODUCT LABEL ISSUE 7 0.0010
264 APHTHOUS ULCER 8 0.0010
265 PHOTOSENSITIVITY REACTION 17 0.0010
266 FEELING HOT 63 0.0010
267 IRRITABLE BOWEL SYNDROME 22 0.0010
268 PALPITATIONS 120 0.0010
269 BACK PAIN 238 0.0010
270 BLOOD TESTOSTERONE DECREASED 7 0.0010
271 VIRAL INFECTION 34 0.0010
272 GASTROINTESTINAL INFLAMMATION 8 0.0010
273 THINKING ABNORMAL 19 0.0010
274 CRYING 37 0.0010
275 GAIT INABILITY 34 0.0010
276 PRODUCT USE COMPLAINT 16 0.0010
277 JOINT EFFUSION 7 0.0010
278 APPLICATION SITE BURN 5 0.0010
279 PANCREATIC DISORDER 5 0.0010
280 PAIN IN EXTREMITY 299 0.0010
281 SINUSITIS 104 0.0010
282 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
283 ROTATOR CUFF SYNDROME 13 0.0010
284 HAIR GROWTH ABNORMAL 7 0.0010
285 SINUS DISORDER 20 0.0010
286 FURUNCLE 8 0.0010
287 CHILLS 118 0.0010
288 HUNGER 14 0.0010
289 DIPLOPIA 26 0.0010
290 FLUID INTAKE REDUCED 5 0.0010
291 DENTAL CARIES 11 0.0010
292 MUSCULAR WEAKNESS 113 0.0010
293 SQUAMOUS CELL CARCINOMA OF SKIN 6 0.0010
294 TOOTH DISORDER 22 0.0010
295 PRODUCT DOSE OMISSION IN ERROR 28 0.0010
296 PAIN IN JAW 28 0.0010
297 FEEDING DISORDER 20 0.0010
298 PATHOLOGICAL FRACTURE 5 0.0010
299 DIVERTICULUM 7 0.0010
300 NIGHTMARE 34 0.0010
301 HOT FLUSH 74 0.0010
302 HYPOAESTHESIA 146 0.0010
303 IRON DEFICIENCY ANAEMIA 9 0.0010
304 SMALL INTESTINAL OBSTRUCTION 12 0.0010
305 DRY MOUTH 79 0.0010
306 EMOTIONAL DISORDER 30 0.0010
307 CONSTIPATION 212 0.0010
308 PARAESTHESIA ORAL 14 0.0010
309 PRODUCT DISTRIBUTION ISSUE 9 0.0010
310 GENERALISED OEDEMA 12 0.0010
311 JOINT RANGE OF MOTION DECREASED 13 0.0010
312 TONGUE DISORDER 7 0.0010
313 COLITIS ULCERATIVE 43 0.0010
314 THROAT TIGHTNESS 26 0.0010
315 HAEMATOCHEZIA 53 0.0010
316 APHASIA 29 0.0010
317 FLANK PAIN 9 0.0010
318 UTERINE LEIOMYOMA 7 0.0010
319 WEIGHT FLUCTUATION 10 0.0010
320 PARTIAL SEIZURES 5 0.0010
321 SLEEP DISORDER 67 0.0009
322 GOUT 17 0.0009
323 MUSCLE ATROPHY 12 0.0009
324 ELECTROLYTE IMBALANCE 11 0.0009
325 PERIPHERAL COLDNESS 13 0.0009
326 MUSCULOSKELETAL DISORDER 18 0.0009
327 HYPERSOMNIA 27 0.0009
328 FACIAL PARALYSIS 8 0.0009
329 SEXUAL DYSFUNCTION 11 0.0009
330 NEPHROLITHIASIS 43 0.0009
331 ANAL FISTULA 5 0.0009
332 JOINT INJURY 20 0.0009
333 NASAL CONGESTION 55 0.0009
334 FEELING ABNORMAL 224 0.0009
335 GASTROINTESTINAL MOTILITY DISORDER 5 0.0009
336 VISION BLURRED 128 0.0009
337 ANAL FISSURE 5 0.0009
338 BLOOD POTASSIUM DECREASED 28 0.0009
339 HERNIA 18 0.0009
340 MUSCULOSKELETAL DISCOMFORT 16 0.0009
341 GINGIVITIS 5 0.0009
342 MUSCLE STRAIN 8 0.0009
343 CHEILITIS 5 0.0009
344 INJECTION SITE WARMTH 19 0.0009
345 ERYTHEMA OF EYELID 5 0.0009
346 HAEMORRHOIDS 18 0.0009
347 INSOMNIA 245 0.0009
348 HEAD INJURY 29 0.0009
349 INJECTION SITE BRUISING 73 0.0009
350 JOINT STIFFNESS 24 0.0009
351 ARTHRALGIA 379 0.0009
352 IMMUNE SYSTEM DISORDER 12 0.0009
353 UPPER RESPIRATORY TRACT INFECTION 42 0.0009
354 MENTAL IMPAIRMENT 22 0.0009
355 FOOD ALLERGY 7 0.0009
356 WITHDRAWAL SYNDROME 38 0.0009
357 INTESTINAL OBSTRUCTION 34 0.0009
358 NIGHT SWEATS 29 0.0009
359 INJECTION SITE PRURITUS 60 0.0009
360 GLOSSODYNIA 20 0.0009
361 RASH PAPULAR 20 0.0009
362 FEAR 24 0.0009
363 FEELING JITTERY 17 0.0009
364 SNEEZING 20 0.0009
365 THROAT IRRITATION 40 0.0009
366 APATHY 13 0.0009
367 ABASIA 22 0.0009
368 DISTURBANCE IN ATTENTION 48 0.0009
369 VAGINAL DISCHARGE 9 0.0009
370 CANDIDA INFECTION 15 0.0009
371 DIZZINESS 443 0.0009
372 ABDOMINAL PAIN UPPER 182 0.0009
373 HAIR COLOUR CHANGES 11 0.0009
374 POOR QUALITY SLEEP 19 0.0009
375 BLOOD ALBUMIN DECREASED 7 0.0009
376 PNEUMONIA ASPIRATION 22 0.0009
377 PRODUCTIVE COUGH 42 0.0009
378 GENERALISED ERYTHEMA 5 0.0009
379 PRURITUS GENERALISED 19 0.0009
380 MOOD SWINGS 28 0.0009
381 MULTIPLE SCLEROSIS 42 0.0009
382 SECRETION DISCHARGE 11 0.0009
383 ARTHRITIS 69 0.0009
384 EXOSTOSIS 8 0.0009
385 PULMONARY MASS 13 0.0009
386 OBSESSIVE-COMPULSIVE DISORDER 7 0.0009
387 MIOSIS 7 0.0009
388 CLOSTRIDIUM DIFFICILE INFECTION 19 0.0009
389 NEOPLASM 10 0.0009
390 ABNORMAL DREAMS 24 0.0009
391 LARGE INTESTINE POLYP 6 0.0009
392 FATIGUE 673 0.0009
393 DYSPEPSIA 85 0.0009
394 TENDERNESS 9 0.0009
395 PERSONALITY CHANGE 8 0.0009
396 RASH MACULAR 30 0.0009
397 HAEMATOCRIT DECREASED 17 0.0009
398 BLOOD PRESSURE ABNORMAL 17 0.0009
399 PAPULE 6 0.0009
400 EYE DISORDER 28 0.0009
401 RENAL PAIN 9 0.0008
402 CYSTITIS 27 0.0008
403 HEART RATE INCREASED 84 0.0008
404 MEMORY IMPAIRMENT 116 0.0008
405 PERIPHERAL SWELLING 130 0.0008
406 OROPHARYNGEAL PAIN 78 0.0008
407 CONTUSION 81 0.0008
408 DEAFNESS 22 0.0008
409 PRODUCT SUPPLY ISSUE 6 0.0008
410 LIMB DISCOMFORT 26 0.0008
411 SPEECH DISORDER 44 0.0008
412 RED BLOOD CELL COUNT DECREASED 24 0.0008
413 CARDIAC PACEMAKER INSERTION 5 0.0008
414 EYE INFLAMMATION 8 0.0008
415 ACCIDENT 10 0.0008
416 TOOTH INFECTION 11 0.0008
417 DECREASED ACTIVITY 9 0.0008
418 ANXIETY 237 0.0008
419 PANIC REACTION 6 0.0008
420 VISUAL FIELD DEFECT 6 0.0008
421 ANOSMIA 12 0.0008
422 OSTEOARTHRITIS 35 0.0008
423 MAJOR DEPRESSION 6 0.0008
424 URINARY TRACT INFECTION 140 0.0008
425 INJECTION SITE NODULE 9 0.0008
426 EYE IRRITATION 47 0.0008
427 ASTHENIA 307 0.0008
428 ABDOMINAL DISTENSION 85 0.0008
429 SWELLING FACE 53 0.0008
430 MENISCUS INJURY 5 0.0008
431 FOOT DEFORMITY 9 0.0008
432 RASH PRURITIC 44 0.0008
433 CEREBRAL DISORDER 6 0.0008
434 DIARRHOEA 523 0.0008
435 NERVE INJURY 9 0.0008
436 EYE SWELLING 30 0.0008
437 SKIN DISCOLOURATION 37 0.0008
438 URINE OUTPUT DECREASED 7 0.0008
439 BACK DISORDER 13 0.0008
440 BLOOD SODIUM DECREASED 15 0.0008
441 MITRAL VALVE INCOMPETENCE 9 0.0008
442 RASH ERYTHEMATOUS 38 0.0008
443 BLEPHAROSPASM 5 0.0008
444 IMMUNOSUPPRESSION 7 0.0008
445 ABDOMINAL PAIN LOWER 20 0.0008
446 FEELING COLD 22 0.0008
447 DRUG LEVEL DECREASED 8 0.0008
448 MOTOR DYSFUNCTION 8 0.0008
449 HYPERHIDROSIS 101 0.0008
450 DEPRESSION 178 0.0008
451 FUNGAL INFECTION 26 0.0008
452 PHARYNGEAL OEDEMA 12 0.0008
453 HAEMOGLOBIN ABNORMAL 5 0.0008
454 HEADACHE 485 0.0008
455 CARDIAC FLUTTER 5 0.0008
456 INJECTION SITE INDURATION 10 0.0008
457 CHOKING 15 0.0008
458 SPINAL PAIN 9 0.0008
459 NERVOUSNESS 40 0.0008
460 MUSCULOSKELETAL STIFFNESS 67 0.0008
461 KIDNEY INFECTION 15 0.0008
462 POLYP 5 0.0008
463 INJECTION SITE PAIN 234 0.0008
464 MYELODYSPLASTIC SYNDROME 11 0.0008
465 ORAL PAIN 17 0.0008
466 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 13 0.0008
467 DIVERTICULITIS 21 0.0008
468 GASTRIC DISORDER 26 0.0008
469 INJECTION SITE MASS 28 0.0008
470 ABDOMINAL DISCOMFORT 127 0.0008
471 APPETITE DISORDER 5 0.0008
472 BONE PAIN 44 0.0008
473 SENSORY DISTURBANCE 12 0.0007
474 HEREDITARY ANGIOEDEMA 8 0.0007
475 RHINITIS 6 0.0007
476 WRONG TECHNIQUE IN DRUG USAGE PROCESS 27 0.0007
477 SKIN CANCER 16 0.0007
478 HEART RATE DECREASED 26 0.0007
479 DISCOMFORT 45 0.0007
480 DYSPHAGIA 70 0.0007
481 LYMPHOCYTE COUNT DECREASED 13 0.0007
482 MENTAL DISORDER 32 0.0007
483 SKIN ULCER 19 0.0007
484 PULMONARY THROMBOSIS 8 0.0007
485 DYSURIA 27 0.0007
486 INTERVERTEBRAL DISC PROTRUSION 16 0.0007
487 ABDOMINAL PAIN 170 0.0007
488 EYE MOVEMENT DISORDER 5 0.0007
489 BLISTER 41 0.0007
490 RIB FRACTURE 15 0.0007
491 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
492 ECONOMIC PROBLEM 11 0.0007
493 BLOOD COUNT ABNORMAL 11 0.0007
494 PAIN 445 0.0007
495 NASOPHARYNGITIS 133 0.0007
496 DRY EYE 36 0.0007
497 FALL 240 0.0007
498 SUICIDAL IDEATION 66 0.0007
499 DEHYDRATION 96 0.0007
500 ORAL DISCOMFORT 10 0.0007
501 VISUAL IMPAIRMENT 89 0.0007
502 INFLAMMATION 37 0.0007
503 THYROID DISORDER 11 0.0007
504 WEIGHT DECREASED 199 0.0007
505 SENSATION OF FOREIGN BODY 6 0.0007
506 BLOOD CALCIUM DECREASED 8 0.0007
507 ANKLE FRACTURE 11 0.0007
508 DECREASED APPETITE 165 0.0007
509 CHROMATURIA 16 0.0007
510 HOSPICE CARE 7 0.0007
511 LIGAMENT SPRAIN 7 0.0007
512 NERVOUS SYSTEM DISORDER 22 0.0007
513 SWOLLEN TONGUE 22 0.0007
514 HYPOPHAGIA 18 0.0007
515 LOCALISED INFECTION 17 0.0007
516 OVARIAN CYST 7 0.0007
517 CARDIAC OPERATION 6 0.0007
518 WEIGHT INCREASED 156 0.0007
519 RASH GENERALISED 18 0.0007
520 NAUSEA 549 0.0007
521 CHEST DISCOMFORT 71 0.0007
522 SKIN SWELLING 6 0.0007
523 NODULE 9 0.0007
524 CATARACT 41 0.0007
525 ALOPECIA 135 0.0007
526 PRURITUS 264 0.0007
527 NAIL DISORDER 6 0.0007
528 FOOT FRACTURE 13 0.0007
529 LIQUID PRODUCT PHYSICAL ISSUE 5 0.0007
530 SWELLING 64 0.0007
531 SLEEP APNOEA SYNDROME 13 0.0007
532 COLD SWEAT 12 0.0007
533 CHEST PAIN 126 0.0007
534 LYMPHADENOPATHY 24 0.0007
535 BLOOD POTASSIUM INCREASED 11 0.0007
536 HYPOPHOSPHATAEMIA 5 0.0007
537 EAR INFECTION 18 0.0007
538 BRONCHITIS 50 0.0007
539 VENTRICULAR EXTRASYSTOLES 7 0.0007
540 EYE DISCHARGE 7 0.0007
541 DYSGEUSIA 50 0.0007
542 MULTIPLE SCLEROSIS RELAPSE 46 0.0007
543 CHOLELITHIASIS 22 0.0007
544 BLOOD PRESSURE FLUCTUATION 16 0.0007
545 ORAL HERPES 13 0.0007
546 SOMNOLENCE 134 0.0007
547 BREAST TENDERNESS 5 0.0007
548 LIP DRY 6 0.0007
549 OPTIC NEURITIS 6 0.0007
550 AKATHISIA 9 0.0007
551 OSTEOPENIA 10 0.0007
552 CENTRAL NERVOUS SYSTEM LESION 9 0.0007
553 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0007
554 INJECTION SITE URTICARIA 16 0.0007
555 PROCEDURAL COMPLICATION 5 0.0007
556 CARDIOMEGALY 8 0.0006
557 ILLNESS 67 0.0006
558 RENAL FAILURE CHRONIC 5 0.0006
559 BLOOD GLUCOSE ABNORMAL 12 0.0006
560 SPINAL OPERATION 8 0.0006
561 GASTROINTESTINAL DISORDER 58 0.0006
562 PHARYNGITIS 8 0.0006
563 APHONIA 9 0.0006
564 CONFUSIONAL STATE 104 0.0006
565 DEPRESSED MOOD 34 0.0006
566 LETHARGY 37 0.0006
567 BLOOD TEST ABNORMAL 9 0.0006
568 INJECTION SITE DISCOLOURATION 8 0.0006
569 BLINDNESS UNILATERAL 9 0.0006
570 JOINT SWELLING 77 0.0006
571 SQUAMOUS CELL CARCINOMA 6 0.0006
572 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
573 SPUTUM DISCOLOURED 6 0.0006
574 OSTEOPOROSIS 26 0.0006
575 SEIZURE 73 0.0006
576 THERAPY INTERRUPTED 45 0.0006
577 SKIN DISORDER 21 0.0006
578 RESTLESSNESS 23 0.0006
579 INFLUENZA 70 0.0006
580 ATRIAL FLUTTER 5 0.0006
581 SKIN INFECTION 7 0.0006
582 MOOD ALTERED 17 0.0006
583 BLOOD TRIGLYCERIDES INCREASED 11 0.0006
584 RENAL DISORDER 29 0.0006
585 URTICARIA 104 0.0006
586 INJECTION SITE ERYTHEMA 77 0.0006
587 HEART RATE IRREGULAR 14 0.0006
588 REBOUND EFFECT 7 0.0006
589 MYASTHENIA GRAVIS 5 0.0006
590 MALAISE 271 0.0006
591 DYSKINESIA 25 0.0006
592 POST PROCEDURAL INFECTION 5 0.0006
593 INJECTION SITE HAEMORRHAGE 49 0.0006
594 LABORATORY TEST ABNORMAL 18 0.0006
595 COUGH 171 0.0006
596 COMA 29 0.0006
597 GASTRITIS 16 0.0006
598 ORAL CANDIDIASIS 8 0.0006
599 DYSPNOEA 343 0.0006
600 PELVIC PAIN 11 0.0006
601 INABILITY TO AFFORD MEDICATION 6 0.0006
602 UPPER LIMB FRACTURE 12 0.0006
603 THERAPEUTIC RESPONSE UNEXPECTED 27 0.0006
604 COAGULOPATHY 10 0.0006
605 SALIVARY HYPERSECRETION 6 0.0006
606 EYE HAEMORRHAGE 8 0.0006
607 SPINAL FRACTURE 12 0.0006
608 OEDEMA PERIPHERAL 73 0.0006
609 HEPATIC STEATOSIS 11 0.0006
610 OCULAR HYPERAEMIA 28 0.0006
611 UVEITIS 8 0.0006
612 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 10 0.0006
613 BODY TEMPERATURE INCREASED 12 0.0006
614 NEUTROPHIL COUNT INCREASED 6 0.0006
615 HEPATIC CIRRHOSIS 11 0.0006
616 CORONARY ARTERY OCCLUSION 8 0.0006
617 PSEUDOMONAS INFECTION 5 0.0006
618 IRRITABILITY 35 0.0006
619 APPLICATION SITE RASH 8 0.0006
620 TOOTH LOSS 12 0.0006
621 IMPAIRED HEALING 19 0.0006
622 HAEMOPTYSIS 16 0.0006
623 RASH 250 0.0006
624 VOMITING 269 0.0006
625 MOBILITY DECREASED 41 0.0006
626 BLOOD CALCIUM INCREASED 5 0.0006
627 SYNCOPE 57 0.0006
628 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
629 PRESCRIBED OVERDOSE 11 0.0006
630 HALLUCINATION, VISUAL 12 0.0006
631 FULL BLOOD COUNT ABNORMAL 6 0.0006
632 RESPIRATORY TRACT CONGESTION 9 0.0006
633 HYPERSENSITIVITY 105 0.0006
634 EPISTAXIS 42 0.0006
635 INTENTIONAL DOSE OMISSION 16 0.0006
636 HIP FRACTURE 18 0.0006
637 THROMBOSIS 45 0.0006
638 RECTAL HAEMORRHAGE 24 0.0006
639 ARTHROPATHY 31 0.0006
640 ASTHMA 63 0.0006
641 LOSS OF LIBIDO 5 0.0006
642 BRAIN OEDEMA 7 0.0006
643 INJECTION SITE RASH 17 0.0006
644 OROPHARYNGEAL DISCOMFORT 5 0.0006
645 INJECTION SITE REACTION 38 0.0006
646 PRODUCT QUALITY ISSUE 75 0.0006
647 PALLOR 15 0.0006
648 PRODUCT PRESCRIBING ISSUE 12 0.0006
649 INJECTION SITE SWELLING 42 0.0005
650 INTRAOCULAR PRESSURE INCREASED 7 0.0005
651 FULL BLOOD COUNT DECREASED 11 0.0005
652 STAPHYLOCOCCAL INFECTION 18 0.0005
653 HAEMOGLOBIN DECREASED 56 0.0005
654 PRODUCT PHYSICAL ISSUE 11 0.0005
655 SKIN EXFOLIATION 46 0.0005
656 ERYTHEMA 112 0.0005
657 PNEUMONIA BACTERIAL 5 0.0005
658 HALLUCINATION 41 0.0005
659 RETINAL DETACHMENT 5 0.0005
660 OVARIAN CANCER 5 0.0005
661 SKIN HAEMORRHAGE 8 0.0005
662 OBSTRUCTIVE AIRWAYS DISORDER 6 0.0005
663 BLOOD UREA INCREASED 9 0.0005
664 PRODUCT DOSE OMISSION ISSUE 158 0.0005
665 OCULAR DISCOMFORT 6 0.0005
666 HYPOTHYROIDISM 17 0.0005
667 LACERATION 5 0.0005
668 EYE INFECTION 6 0.0005
669 ANKYLOSING SPONDYLITIS 7 0.0005
670 DISORIENTATION 21 0.0005
671 APPLICATION SITE PRURITUS 12 0.0005
672 INFUSION RELATED REACTION 35 0.0005
673 BLOOD URINE PRESENT 10 0.0005
674 INTENTIONAL DRUG MISUSE 11 0.0005
675 CHOLECYSTECTOMY 6 0.0005
676 ANGINA PECTORIS 15 0.0005
677 PULMONARY FIBROSIS 10 0.0005
678 WHITE BLOOD CELL COUNT INCREASED 20 0.0005
679 DRUG DOSE OMISSION 86 0.0005
680 ORTHOSTATIC HYPOTENSION 9 0.0005
681 ERUCTATION 10 0.0005
682 EATING DISORDER 11 0.0005
683 LIMB INJURY 14 0.0005
684 POST PROCEDURAL HAEMORRHAGE 6 0.0005
685 LOSS OF CONSCIOUSNESS 66 0.0005
686 DELUSION 8 0.0005
687 IMPAIRED GASTRIC EMPTYING 7 0.0005
688 AUTOIMMUNE DISORDER 5 0.0005
689 GINGIVAL BLEEDING 7 0.0005
690 URINARY RETENTION 17 0.0005
691 URINARY INCONTINENCE 15 0.0005
692 ATAXIA 6 0.0005
693 ABNORMAL BEHAVIOUR 20 0.0005
694 MENTAL STATUS CHANGES 14 0.0005
695 MYOCLONUS 6 0.0005
696 MUSCLE RIGIDITY 6 0.0005
697 DEMENTIA 14 0.0005
698 HEPATIC ENZYME INCREASED 34 0.0005
699 BRAIN INJURY 5 0.0005
700 OSTEOMYELITIS 9 0.0005
701 EMPHYSEMA 5 0.0005
702 BURSITIS 6 0.0005
703 DRY SKIN 66 0.0005
704 NO THERAPEUTIC RESPONSE 6 0.0005
705 EYELID PTOSIS 5 0.0005
706 PRODUCT DOSE OMISSION 32 0.0005
707 SKIN BURNING SENSATION 35 0.0005
708 HYPOACUSIS 21 0.0005
709 GENERALISED TONIC-CLONIC SEIZURE 8 0.0005
710 ATRIAL FIBRILLATION 47 0.0005
711 PNEUMONIA 156 0.0005
712 VISUAL ACUITY REDUCED 16 0.0005
713 LIVER FUNCTION TEST ABNORMAL 14 0.0005
714 LIP SWELLING 16 0.0005
715 SKIN IRRITATION 22 0.0005
716 PYREXIA 166 0.0005
717 WHITE BLOOD CELL COUNT DECREASED 52 0.0005
718 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 25 0.0005
719 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 23 0.0005
720 DYSARTHRIA 18 0.0005
721 ECZEMA 25 0.0005
722 GLYCOSYLATED HAEMOGLOBIN INCREASED 12 0.0005
723 TRANSIENT ISCHAEMIC ATTACK 16 0.0005
724 CARDIOMYOPATHY 7 0.0005
725 HAEMATEMESIS 12 0.0005
726 HYPERTENSION 100 0.0005
727 ANAEMIA 90 0.0005
728 FLUID RETENTION 24 0.0005
729 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
730 RENAL FAILURE ACUTE 20 0.0005
731 HERPES ZOSTER 27 0.0005
732 COLON CANCER 7 0.0005
733 DEVICE MALFUNCTION 33 0.0005
734 BREAST PAIN 5 0.0005
735 LOWER LIMB FRACTURE 9 0.0005
736 PSORIATIC ARTHROPATHY 19 0.0005
737 MYDRIASIS 6 0.0005
738 BLINDNESS 19 0.0005
739 ANOREXIA 6 0.0005
740 DRUG EFFECT DECREASED 25 0.0005
741 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 33 0.0005
742 AGITATION 34 0.0005
743 PHARYNGITIS STREPTOCOCCAL 5 0.0005
744 STOMATITIS 28 0.0005
745 RESPIRATORY TRACT INFECTION 12 0.0005
746 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 83 0.0005
747 BACK INJURY 5 0.0005
748 OESOPHAGITIS 5 0.0005
749 ASPIRATION 5 0.0005
750 COVID-19 80 0.0005
751 METASTASES TO LIVER 8 0.0005
752 PULMONARY CONGESTION 6 0.0005
753 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
754 HYPOGLYCAEMIA 22 0.0005
755 ADVERSE REACTION 6 0.0005
756 PSORIASIS 59 0.0005
757 BLOOD PRESSURE DECREASED 30 0.0005
758 LIVER DISORDER 20 0.0005
759 CARDIAC DISORDER 42 0.0004
760 BASAL CELL CARCINOMA 7 0.0004
761 GALLBLADDER DISORDER 8 0.0004
762 MALIGNANT MELANOMA 6 0.0004
763 CHRONIC KIDNEY DISEASE 34 0.0004
764 ADVERSE DRUG REACTION 40 0.0004
765 FISTULA 5 0.0004
766 ARRHYTHMIA 21 0.0004
767 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
768 HALLUCINATION, AUDITORY 7 0.0004
769 ABSCESS 7 0.0004
770 INTERNAL HAEMORRHAGE 5 0.0004
771 BLOOD GLUCOSE DECREASED 21 0.0004
772 UNEVALUABLE EVENT 33 0.0004
773 PRODUCT COMPLAINT 11 0.0004
774 INTENTIONAL PRODUCT MISUSE 38 0.0004
775 PROCEDURAL PAIN 12 0.0004
776 PERICARDIAL EFFUSION 10 0.0004
777 HYPOMAGNESAEMIA 6 0.0004
778 GASTROINTESTINAL HAEMORRHAGE 36 0.0004
779 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
780 BLOOD CHOLESTEROL INCREASED 20 0.0004
781 BACTERIAL INFECTION 8 0.0004
782 ERECTILE DYSFUNCTION 11 0.0004
783 MANIA 7 0.0004
784 DYSPNOEA EXERTIONAL 16 0.0004
785 THERAPEUTIC PRODUCT EFFECT DECREASED 19 0.0004
786 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
787 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
788 LIVER FUNCTION TEST INCREASED 9 0.0004
789 HYPERLIPIDAEMIA 5 0.0004
790 CELLULITIS 21 0.0004
791 GLAUCOMA 8 0.0004
792 INFECTION 60 0.0004
793 HYPOKINESIA 6 0.0004
794 PRESYNCOPE 10 0.0004
795 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
796 PLASMA CELL MYELOMA 16 0.0004
797 MELAENA 9 0.0004
798 APPLICATION SITE PAIN 9 0.0004
799 MENORRHAGIA 8 0.0004
800 ROAD TRAFFIC ACCIDENT 17 0.0004
801 RHEUMATOID ARTHRITIS 46 0.0004
802 HYPERCALCAEMIA 5 0.0004
803 CONDITION AGGRAVATED 123 0.0004
804 SKIN LESION 11 0.0004
805 DERMATITIS ALLERGIC 5 0.0004
806 ASPARTATE AMINOTRANSFERASE INCREASED 21 0.0004
807 HIP ARTHROPLASTY 6 0.0004
808 OXYGEN SATURATION DECREASED 22 0.0004
809 HYPOKALAEMIA 18 0.0004
810 TYPE 2 DIABETES MELLITUS 13 0.0004
811 EJECTION FRACTION DECREASED 6 0.0004
812 INJURY 27 0.0004
813 PULMONARY HYPERTENSION 8 0.0004
814 CEREBROVASCULAR ACCIDENT 65 0.0004
815 PLATELET COUNT INCREASED 5 0.0004
816 BLOOD GLUCOSE INCREASED 72 0.0004
817 APPLICATION SITE ERYTHEMA 10 0.0004
818 SARS-COV-2 TEST POSITIVE 5 0.0004
819 THERAPY NON-RESPONDER 17 0.0004
820 FRACTURE 7 0.0004
821 DEEP VEIN THROMBOSIS 24 0.0004
822 HYPOXIA 13 0.0004
823 PULMONARY EMBOLISM 35 0.0004
824 PNEUMONITIS 10 0.0004
825 POST PROCEDURAL COMPLICATION 7 0.0004
826 PROSTATIC SPECIFIC ANTIGEN INCREASED 5 0.0004
827 SURGERY 21 0.0004
828 DRUG EFFECT INCOMPLETE 13 0.0004
829 WOUND 10 0.0004
830 PULMONARY OEDEMA 16 0.0004
831 EYE PRURITUS 12 0.0004
832 ACNE 27 0.0004
833 INCORRECT DRUG ADMINISTRATION DURATION 10 0.0004
834 TARDIVE DYSKINESIA 10 0.0004
835 HEMIPARESIS 6 0.0004
836 PRODUCT AVAILABILITY ISSUE 8 0.0004
837 PREGNANCY 7 0.0003
838 HAEMATOMA 9 0.0003
839 HYPERTHYROIDISM 5 0.0003
840 INJECTION SITE HAEMATOMA 5 0.0003
841 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
842 NEUTROPHIL COUNT DECREASED 14 0.0003
843 COLITIS 13 0.0003
844 ANHEDONIA 9 0.0003
845 DRUG INTOLERANCE 33 0.0003
846 BRADYCARDIA 18 0.0003
847 PLATELET COUNT DECREASED 36 0.0003
848 OFF LABEL USE 294 0.0003
849 IMMUNODEFICIENCY 5 0.0003
850 OSTEONECROSIS 11 0.0003
851 CONVULSION 19 0.0003
852 OEDEMA 18 0.0003
853 SEPSIS 37 0.0003
854 THERAPEUTIC RESPONSE SHORTENED 11 0.0003
855 DRUG WITHDRAWAL SYNDROME 29 0.0003
856 NEOPLASM MALIGNANT 22 0.0003
857 END STAGE RENAL DISEASE 6 0.0003
858 LUNG DISORDER 16 0.0003
859 ENCEPHALOPATHY 8 0.0003
860 ALANINE AMINOTRANSFERASE INCREASED 20 0.0003
861 OSTEONECROSIS OF JAW 8 0.0003
862 PRODUCT DISPENSING ERROR 7 0.0003
863 RENAL IMPAIRMENT 27 0.0003
864 PRODUCT USE ISSUE 60 0.0003
865 LUNG NEOPLASM MALIGNANT 13 0.0003
866 GASTRIC ULCER 6 0.0003
867 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
868 PNEUMOTHORAX 5 0.0003
869 TACHYCARDIA 28 0.0003
870 DIABETES MELLITUS 24 0.0003
871 DRUG INEFFECTIVE 414 0.0003
872 PREMATURE DELIVERY 5 0.0003
873 ILL-DEFINED DISORDER 19 0.0003
874 HEPATITIS 8 0.0003
875 DRUG PRESCRIBING ERROR 6 0.0003
876 CARDIAC FAILURE CONGESTIVE 25 0.0003
877 UNRESPONSIVE TO STIMULI 8 0.0003
878 PHARMACEUTICAL PRODUCT COMPLAINT 8 0.0003
879 SKIN FISSURES 6 0.0003
880 INCORRECT DOSE ADMINISTERED 70 0.0003
881 AGGRESSION 15 0.0003
882 HYPOTENSION 60 0.0003
883 MYOCARDIAL INFARCTION 52 0.0003
884 JAUNDICE 8 0.0003
885 PRODUCT ADMINISTRATION ERROR 6 0.0003
886 HAEMORRHAGE 31 0.0003
887 RENAL FAILURE 39 0.0003
888 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
889 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
890 INTENTIONAL PRODUCT USE ISSUE 25 0.0003
891 DERMATITIS ATOPIC 15 0.0003
892 ISCHAEMIC STROKE 5 0.0003
893 HOSPITALISATION 43 0.0003
894 DISEASE PROGRESSION 33 0.0003
895 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
896 LEUKOCYTOSIS 5 0.0003
897 NEEDLE ISSUE 8 0.0003
898 HYPERGLYCAEMIA 10 0.0003
899 DISEASE RECURRENCE 13 0.0003
900 ANAPHYLACTIC SHOCK 7 0.0003
901 WHEEZING 16 0.0003
902 AGRANULOCYTOSIS 5 0.0003
903 HYPOCALCAEMIA 5 0.0003
904 PLEURAL EFFUSION 16 0.0003
905 HAEMATURIA 9 0.0003
906 BREAST CANCER FEMALE 7 0.0003
907 INCREASED APPETITE 5 0.0003
908 DRUG ADMINISTRATION ERROR 8 0.0003
909 BLOOD BILIRUBIN INCREASED 7 0.0003
910 FEMUR FRACTURE 8 0.0003
911 TREATMENT NONCOMPLIANCE 14 0.0003
912 DISABILITY 5 0.0003
913 SEPTIC SHOCK 11 0.0003
914 MEDICATION ERROR 14 0.0003
915 PRESCRIBED UNDERDOSE 5 0.0003
916 PANCYTOPENIA 14 0.0003
917 DIABETIC KETOACIDOSIS 6 0.0002
918 HEPATIC CANCER 6 0.0002
919 UNDERDOSE 18 0.0002
920 PANCREATITIS 13 0.0002
921 CEREBRAL INFARCTION 6 0.0002
922 BLOOD CREATININE INCREASED 16 0.0002
923 MALIGNANT NEOPLASM PROGRESSION 25 0.0002
924 PANCREATIC CARCINOMA 7 0.0002
925 GENERAL PHYSICAL HEALTH DETERIORATION 28 0.0002
926 DRUG INTERACTION 38 0.0002
927 DEATH 206 0.0002
928 DERMATITIS 5 0.0002
929 KNEE ARTHROPLASTY 5 0.0002
930 RENAL INJURY 7 0.0002
931 ANAPHYLACTIC REACTION 13 0.0002
932 HEPATIC FAILURE 7 0.0002
933 DEVICE DISLOCATION 10 0.0002
934 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
935 MENSTRUATION IRREGULAR 6 0.0002
936 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
937 THROMBOCYTOPENIA 25 0.0002
938 CEREBRAL HAEMORRHAGE 8 0.0002
939 EXTRA DOSE ADMINISTERED 9 0.0002
940 C-REACTIVE PROTEIN INCREASED 8 0.0002
941 THERAPEUTIC RESPONSE DECREASED 13 0.0002
942 DEVICE DIFFICULT TO USE 14 0.0002
943 DEVICE LEAKAGE 9 0.0002
944 RESPIRATORY FAILURE 15 0.0002
945 ASCITES 6 0.0002
946 ANGIOEDEMA 9 0.0002
947 PSYCHOTIC DISORDER 6 0.0002
948 HYPERKALAEMIA 7 0.0002
949 PRODUCT ADHESION ISSUE 7 0.0002
950 HYPONATRAEMIA 11 0.0002
951 OVERDOSE 42 0.0002
952 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
953 ACCIDENTAL OVERDOSE 7 0.0002
954 INCORRECT DOSE ADMINISTERED BY DEVICE 5 0.0002
955 EMOTIONAL DISTRESS 23 0.0002
956 DEVICE ISSUE 17 0.0002
957 ACUTE KIDNEY INJURY 29 0.0002
958 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 38 0.0002
959 ADVERSE EVENT 17 0.0002
960 VAGINAL HAEMORRHAGE 8 0.0002
961 NEUTROPENIA 25 0.0002
962 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13 0.0002
963 SUICIDE ATTEMPT 11 0.0002
964 RESPIRATORY ARREST 5 0.0002
965 RESPIRATORY DISTRESS 5 0.0002
966 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
967 DELIRIUM 6 0.0002
968 NEOPLASM PROGRESSION 6 0.0002
969 CARDIAC ARREST 14 0.0002
970 CARDIO-RESPIRATORY ARREST 7 0.0002
971 RESPIRATORY DISORDER 5 0.0002
972 TOXICITY TO VARIOUS AGENTS 28 0.0002
973 CORONARY ARTERY DISEASE 5 0.0002
974 BONE DENSITY DECREASED 5 0.0002
975 PRODUCT USE IN UNAPPROVED INDICATION 39 0.0002
976 FEBRILE NEUTROPENIA 10 0.0002
977 BREAST CANCER 14 0.0002
978 CARDIAC FAILURE 12 0.0001
979 PROSTATE CANCER 12 0.0001
980 EXPOSURE DURING PREGNANCY 8 0.0001
981 ACCIDENTAL EXPOSURE TO PRODUCT 13 0.0001
982 INTERSTITIAL LUNG DISEASE 6 0.0001
983 PRODUCT STORAGE ERROR 10 0.0001
984 TREATMENT FAILURE 8 0.0001
985 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
986 DRUG DOSE OMISSION BY DEVICE 7 0.0001
987 BLADDER CANCER 5 0.0001
988 NO ADVERSE EVENT 15 0.0001
989 DRUG DEPENDENCE 11 0.0001